
Nancy L. Reaven, MA
Advertisement
Articles by Nancy L. Reaven, MA
Advertisement
Latest Updated Articles
Evaluation of the Treatment Gap Between Clinical Guidelines and the Utilization of Renin-Angiotensin-Aldosterone System InhibitorsPublished: September 16th 2015 | Updated:
Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldosterone System InhibitorsPublished: August 31st 2016 | Updated:
All-Cause Costs Increase Exponentially with Increased Chronic Kidney Disease StagePublished: June 21st 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5



